Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions

[1]  L. Pusztai,et al.  Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  L. Meijer,et al.  Cyclin dependent kinase inhibitors , 2003 .

[3]  T. McDonnell,et al.  Expression of p27Kip1 and c-Jun Activation Binding Protein 1 Are Inversely Correlated in Systemic Anaplastic Large Cell Lymphoma , 2003 .

[4]  Michele Pagano,et al.  Deregulated degradation of the cdk inhibitor p27 and malignant transformation. , 2003, Seminars in cancer biology.

[5]  Alfonso Bellacosa,et al.  Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer , 2002, Nature Medicine.

[6]  E. Lam,et al.  Jab1 Co-activation of c-Jun Is Abrogated by the Serine 10-phosphorylated Form of p27Kip1 * , 2002, The Journal of Biological Chemistry.

[7]  E. Ohno,et al.  Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters , 2002, British Journal of Cancer.

[8]  J. Schneider,et al.  Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. , 2002, International journal of oncology.

[9]  J. Jen,et al.  Interaction and colocalization of PGP9.5 with JAB1 and p27Kip1 , 2002, Oncogene.

[10]  Y. Dong,et al.  Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  I. D'Agnano,et al.  Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27kip1 levels , 2001, Oncogene.

[12]  M. Birrer,et al.  The role of p27 in endometrial carcinoma. , 2001, Gynecologic oncology.

[13]  C. Cordon-Cardo,et al.  Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.

[14]  O. Nanni,et al.  Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study , 2000, Breast Cancer Research and Treatment.

[15]  Y. Tsunematsu,et al.  Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma. , 2000, International journal of oncology.

[16]  K. Weinberg,et al.  Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Peterse,et al.  p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long‐term follow‐up , 2000 .

[18]  M. Pagano,et al.  Regulation of the Cdk inhibitor p27 and its deregulation in cancer , 2000, Journal of cellular physiology.

[19]  E. Medrano,et al.  High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas. , 1999, The Journal of investigative dermatology.

[20]  J. Palazzo,et al.  Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. , 1999, Cancer research.

[21]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[22]  B. Werness,et al.  Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  S. Cowper,et al.  Expression of p-27 (kip1) in nevi and melanomas. , 1999, The American Journal of dermatopathology.

[24]  J. Kato,et al.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 , 1999, Nature.

[25]  M. Haugg,et al.  p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells , 1999, Oncogene.

[26]  Philip Smith,et al.  Cyclin‐dependent kinase inhibitor p27Kipl expression and interaction with other cell cycle‐associated proteins in mammary carcinoma , 1999, The Journal of pathology.

[27]  M. Loda,et al.  Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. , 1998, The American journal of pathology.

[28]  M. Furihata,et al.  Positive correlation between P27Kip1 expression and progression of human esophageal squamous cell carcinoma , 1998, International journal of cancer.

[29]  M. Kitagawa,et al.  Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. , 1998, The American journal of pathology.

[30]  J. Nesland,et al.  Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. , 1998, The American journal of pathology.

[31]  M. Loda,et al.  Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. , 1998, Cancer research.

[32]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[33]  Herman Yeger,et al.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.

[34]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[35]  T. Toda,et al.  A new group of conserved coactivators that increase the specificity of AP-1 transcription factors , 1996, Nature.

[36]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[37]  M. Rummukainen,et al.  Observational evidence for chemical ozone depletion over the Arctic in winter 1991–92 , 1995, Nature.

[38]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[39]  F. Hu.  Aging of melanocytes. , 1979, The Journal of investigative dermatology.

[40]  H. Peterse,et al.  p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. , 2000, International journal of cancer.

[41]  穴山 貴嗣.  Positive correlation between p27[KIP1] expression and progression of human esophageal squamous cell carcinoma , 2000 .